Prostate Cancer
Combination of docetaxel and vandetanib in docetaxel-sensitive or resistant PC3 cell line - Abstract
August 19, 2011
Alternative antiandrogen therapy with flutamide in patients with castration-resistant prostate cancer : A single center experience - Abstract
August 19, 2011
Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity - Abstract
August 19, 2011
Editor's Commentary - The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy
August 19, 2011
ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of anti-hormonal therapy - Abstract
August 18, 2011
Progress against cancer in the Netherlands since the late 1980s: An epidemiological evaluation - Abstract
August 18, 2011
Utilization trends in prostate cancer therapy - Abstract
August 17, 2011
Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens - Abstract
August 17, 2011
False-positive screening results in the European Randomized Study of Screening for Prostate Cancer - Abstract
August 17, 2011
A phase II clinical trial of neoadjuvant ketoconazole and docetaxel chemotherapy before radical prostatectomy in high risk patients - Abstract
August 17, 2011
Methods of developing UWIN, the modified American Urological Association symptom score - Abstract
August 17, 2011